StockWatch
·
Pharmaceuticals
Tax & Penalty29 Sept 2026, 10:59 am

Sanofi India Receives ₹16.4 Cr GST Show Cause Notice

AI Summary

Sanofi India Ltd has received a Show Cause Notice from the State Tax Officer, Gujarat, concerning GST matters for FY 2022-23. The notice alleges discrepancies in E-Way Bills versus GSTR-1 filings, reconciliation issues, and ineligible input tax credits. It proposes a demand of ₹16,40,07,641 towards tax, interest, and penalty. The company is reviewing the notice and preparing a response, stating it does not anticipate any adverse financial or operational impact.

Key Highlights

  • Received GST Show Cause Notice for FY 2022-23.
  • Notice alleges discrepancies in GST filings and input tax credits.
  • Proposed demand totals ₹16,40,07,641.
  • Company expects no adverse financial impact.
  • Response to be submitted within the prescribed period.